05 November 2024
05 November 2024
The acquisition is expected to be completed in the first half of 2025.
Ondine’s Phase III trial will investigate its Steriwave system for nasal photodisinfection before surgery.
J&J inherited the Javelin catheter as part of its $13.1bn acquisition of Shockwave Medical, which completed in June 2024.
A study noted an average weight loss of 17.6% with Allurion’s device in patients who had no or less than 5% weight loss with GLP-1 drugs.
Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular lithotripsy catheter.
NeuroMatch Access uses AI to streamline EEG data analysis and allows for real-time collaboration between neurologists.
The Acclaim CI was granted the breakthrough device designation by the FDA in 2019.
The support is crucial for Medicare beneficiaries to gain access to healthcare innovations soon after FDA approval.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
